|
1
|
Simpson E and Santen RJ: Celebrating 75
years of oestradiol. J Mol Endocrinol. 55:T1–T20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brady CW: Liver disease in menopause.
World J Gastroenterol. 21:7613–7620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McGlynn KA, Sahasrabuddhe VV, Campbell PT,
Graubard BI, Chen J, Schwartz LM, Petrick JL, Alavanja MC,
Andreotti G, Boggs DA, et al: Reproductive factors, exogenous
hormone use and risk of hepatocellular carcinoma among US women:
Results from the liver cancer pooling project. Br J Cancer.
112:1266–1272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang D, Hanna DL, Usher J, LoCoco J,
Chaudhari P, Lenz HJ, Setiawan VW and El-Khoueiry A: Impact of sex
on the survival of patients with hepatocellular carcinoma: A
surveillance, epidemiology, and end results analysis. Cancer.
120:3707–3716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanda T, Jiang X and Yokosuka O: Androgen
receptor signaling in hepatocellular carcinoma and pancreatic
cancers. World J Gastroenterol. 20:9229–9236. 2014.PubMed/NCBI
|
|
6
|
Kelly DM, Nettleship JE, Akhtar S,
Muraleedharan V, Sellers DJ, Brooke JC, McLaren DS, Channer KS and
Jones TH: Testosterone suppresses the expression of regulatory
enzymes of fatty acid synthesis and protects against hepatic
steatosis in cholesterol-fed androgen deficient mice. Life Sci.
109:95–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Biegon A, Alexoff DL, Kim SW, Logan J,
Pareto D, Schlyer D, Wang GJ and Fowler JS: Aromatase imaging with
[N-methyl-11C]vorozole PET in healthy men and women. J Nucl Med.
56:580–585. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hata S, Miki Y, Saito R, Ishida K,
Watanabe M and Sasano H: Aromatase in human liver and its diseases.
Cancer Med. 2:305–315. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Van Sinderen ML, Steinberg GR, Jørgensen
SB, To SQ, Knower KC, Clyne CD, Honeyman J, Chow JD, Herridge KA,
Jones ME, et al: Hepatic glucose intolerance precedes hepatic
steatosis in the male aromatase knockout (ArKO) mouse. PloS One.
9:e872302014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sinclair M, Gow PJ, Angus PW, Hoermann R,
Handelsman DJ, Wittert G, Martin S and Grossmann M: High
circulating estrone and low testosterone correlate with adverse
clinical outcomes in men with advanced liver disease. Liver Int.
36:1619–1627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qian X, Zhan Q, Lv L, Zhang H, Hong Z, Li
Y, Xu H, Chai Y, Zhao L and Zhang G: Steroid hormone profiles plus
α-fetoprotein for diagnosing primary liver cancer by liquid
chromatography tandem mass spectrometry. Clin Chim Acta. 457:92–98.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai
W, Qiu Y, Li T, Ma X, Liu Y, et al: Estrogen suppresses
hepatocellular carcinoma cells through ERβ-mediated upregulation of
the NLRP3 inflammasome. Lab Invest. 95:804–816. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baldissera VD, Alves AF, Almeida S,
Porawski M and Giovenardi M: Hepatocellular carcinoma and estrogen
receptors: Polymorphisms and isoforms relations and implications.
Med Hypotheses. 86:67–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen M and Shi H: Sex hormones and their
receptors regulate liver energy homeostasis. Int J Endocrinol.
2015:2942782015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng ML, Xu GL, Zhang CH, Jia WD, Ren WH,
Liu WB, Zhou T, Wang YC, Lu ZL, Liu WF, et al: Aberrant estrogen
receptor alpha expression correlates with hepatocellular carcinoma
metastasis and its mechanisms. Hepatogastroenterology. 61:146–150.
2014.PubMed/NCBI
|
|
16
|
Ahmed HH, Shousha WG, Shalby AB,
El-Mezayen HA, Ismaiel NN and Mahmoud NS: Implications of sex
hormone receptor gene expression in the predominance of
hepatocellular carcinoma in males: Role of natural products. Asian
Pac J Cancer Prev. 16:4949–4954. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Chen L and Chang HT: Potential
diagnostic and prognostic biomarkers for cholangiocarcinoma in
serum and bile. Biomark Med. 10:613–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Isse K, Specht SM, Lunz JG III, Kang LI,
Mizuguchi Y and Demetris AJ: Estrogen stimulates female biliary
epithelial cell interleukin-6 expression in mice and humans.
Hepatology. 51:869–880. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hunsawong T, Singsuksawat E, In-chon N,
Chawengrattanachot W, Thuwajit C, Sripa B, Paupairoj A, Chau-in S
and Thuwajit P: Estrogen is increased in male cholangiocarcinoma
patients' serum and stimulates invasion in cholangiocarcinoma cell
lines in vitro. J Cancer Res Clin Oncol. 138:1311–1320. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singsuksawat E, Thuwajit C, Charngkaew K
and Thuwajit P: Increased ETV4 expression correlates with
estrogen-enhanced proliferation and invasiveness of
cholangiocarcinoma cells. Cancer Cell Int. 18:252018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marzioni M, Torrice A, Saccomanno S,
Rychlicki C, Agostinelli L, Pierantonelli I, Rhönnstad P, Trozzi L,
Apelqvist T, Gentile R, et al: An oestrogen receptor β-selective
agonist exerts anti-neoplastic effects in experimental intrahepatic
cholangiocarcinoma. Dig Liver Dis. 44:134–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J and Li Q: Review of the in vivo
functions of the p160 steroid receptor coactivator family. Mol
Endocrinol. 17:1681–1692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
York B and O'Malley BW: Steroid receptor
coactivator (SRC) family: Masters of systems biology. J Biol Chem.
285:38743–38750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu J, Wu RC and O'Malley BW: Normal and
cancer-related functions of the p160 steroid receptor co-activator
(SRC) family. Nat Rev Cancer. 9:615–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin L, Liu Z, Chen H and Xu J: The steroid
receptor coactivator-1 regulates twist expression and promotes
breast cancer metastasis. Cancer Res. 69:3819–3827. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin L, Chen X, Wu Y, Feng Z, He T, Wang L,
Liao L and Xu J: Steroid receptor coactivator-1 upregulates
integrin α5 expression to promote breast cancer cell
adhesion and migration. Cancer Res. 71:1742–1751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Duan C, Bian C, Xiong Y and Zhang
J: Steroid receptor coactivator-1: A versatile regulator and
promising therapeutic target for breast cancer. J Steroid Biochem
Mol Biol. 138:17–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song X, Zhang C, Zhao M, Chen H, Liu X,
Chen J, Lonard DM, Qin L, Xu J, Wang X, et al: Steroid receptor
coactivator-3 (SRC-3/AIB1) as a novel therapeutic target in triple
negative breast cancer and its inhibition with a phospho-bufalin
prodrug. PLoS One. 10:e01400112015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang H, Zhang D, Wu W, Zhang J, Guo D,
Wang Q, Jing T, Xu C, Bian X and Yang K: Overexpression and
gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity
in human non-small cell lung cancer: An in vivo study. J Histochem
Cytochem. 58:1121–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo F, Li W, Zhang J, Huang K, Fu J and
Xie Z: Overexpression of steroid receptor coactivator-3 in bone
cancers: An in vivo immunohistochemical study with tissue
microarray. Pathol Res Pract. 209:790–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li W, Fu J, Bian C, Zhang J and Xie Z:
Immunohistochemical localization of steroid receptor coactivators
in chondrosarcoma: An in vivo tissue microarray study. Pathol Res
Pract. 210:1005–1010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu C, Zhang Y, Zhang K, Bian C, Zhao Y
and Zhang J: Expression of estrogen receptors, androgen receptor
and steroid receptor coactivator-3 is negatively correlated to the
differentiation of astrocytic tumors. Cancer Epidemiol. 38:291–297.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Zhang K, Zhao Y, Guo Q, Guo D and
Zhang J: Evidence for involvement of steroid receptors and
coactivators in neuroepithelial and meningothelial tumors. Tumour
Biol. 36:3251–3261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jeong JW, Kwak I, Lee KY, White LD, Wang
XP, Brunicardi FC, O'Malley BW and DeMayo FJ: The genomic analysis
of the impact of steroid receptor coactivators ablation on hepatic
metabolism. Mol Endocrinol. 20:1138–1152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Louet JF, Chopra AR, Sagen JV, An J, York
B, Tannour-Louet M, Saha PK, Stevens RD, Wenner BR, Ilkayeva OR, et
al: The coactivator SRC-1 is an essential coordinator of hepatic
glucose production. Cell Metab. 12:606–618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Motamed M, Rajapakshe KI, Hartig SM,
Coarfa C, Moses RE, Lonard DM and O'Malley BW: Steroid receptor
coactivator 1 is an integrator of glucose and NAD+/NADH
homeostasis. Mol Endocrinol. 28:395–405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tannour-Louet M, York B, Tang K, Stashi E,
Bouguerra H, Zhou S, Yu H, Wong LJ, Stevens RD, Xu J, et al:
Hepatic SRC-1 activity orchestrates transcriptional circuitries of
amino acid pathways with potential relevance for human metabolic
pathogenesis. Mol Endocrinol. 28:1707–1718. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hansel MC, Davila JC, Vosough M,
Gramignoli R, Skvorak KJ, Dorko K, Marongiu F, Blake W and Strom
SC: The use of induced pluripotent stem cells for the study and
treatment of liver diseases. Curr Protoc Toxicol. 67:14 13 11–14 13
27. 2016.
|
|
39
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang D, Guo Q, Bian C, Zhang J, Lin S and
Su B: Alterations of steroid receptor coactivator-1 (SRC-1)
immunoreactivities in specific brain regions of young and
middle-aged female Sprague-Dawley rats. Brain Res. 1382:88–97.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Anzick SL, Kononen J, Walker RL, Azorsa
DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and
Meltzer PS: AIB1, a steroid receptor coactivator amplified in
breast and ovarian cancer. Science. 277:965–968. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Culig Z, Klocker H, Bartsch G and Hobisch
A: Androgen receptors in prostate cancer. Endocr Relat Cancer.
9:155–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kershah SM, Desouki MM, Koterba KL and
Rowan BG: Expression of estrogen receptor coregulators in normal
and malignant human endometrium. Gynecol Oncol. 92:304–313. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie D, Sham JS, Zeng WF, Lin HL, Bi J, Che
LH, Hu L, Zeng YX and Guan XY: Correlation of AIB1 overexpression
with advanced clinical stage of human colorectal carcinoma. Hum
Pathol. 36:777–783. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Glaeser M, Floetotto T, Hanstein B,
Beckmann MW and Niederacher D: Gene amplification and expression of
the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and
endometrial carcinomas. Horm Metab Res. 33:121–126. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu FP, Xie D, Wen JM, Wu HX, Liu YD, Bi J,
Lv ZL, Zeng YX and Guan XY: SRC-3/AIB1 protein and gene
amplification levels in human esophageal squamous cell carcinomas.
Cancer Lett. 245:69–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sakakura C, Hagiwara A, Yasuoka R, Fujita
Y, Nakanishi M, Masuda K, Kimura A, Nakamura Y, Inazawa J, Abe T
and Yamagishi H: Amplification and over-expression of the AIB1
nuclear receptor co-activator gene in primary gastric cancers. Int
J Cancer. 89:217–223. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yoshida H, Liu J, Samuel S, Cheng W, Rosen
D and Naora H: Steroid receptor coactivator-3, a homolog of Taiman
that controls cell migration in the Drosophila ovary, regulates
migration of human ovarian cancer cells. Mol Cell Endocrinol.
245:77–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Henke RT, Haddad BR, Kim SE, Rone JD, Mani
A, Jessup JM, Wellstein A, Maitra A and Riegel AT: Overexpression
of the nuclear receptor coactivator AIB1 (SRC-3) during progression
of pancreatic adenocarcinoma. Clin Cancer Res. 10:6134–6142. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Uchikawa J, Shiozawa T, Shih HC, Miyamoto
T, Feng YZ, Kashima H, Oka K and Konishi I: Expression of steroid
receptor coactivators and corepressors in human endometrial
hyperplasia and carcinoma with relevance to steroid receptors and
Ki-67 expression. Cancer. 98:2207–2213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Martínez-Jiménez CP, Gómez-Lechón MJ,
Castell JV and Jover R: Underexpressed coactivators PGC1alpha and
SRC1 impair hepatocyte nuclear factor 4 alpha function and promote
dedifferentiation in human hepatoma cells. J Biol Chem.
281:29840–29849. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tong Z, Li M, Wang W, Mo P, Yu L, Liu K,
Ren W, Li W, Zhang H, Xu J and Yu C: Steroid receptor coactivator 1
promotes human hepatocellular carcinoma progression by enhancing
Wnt/β-catenin signaling. J Biol Chem. 290:18596–18608. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ma X, Xu L, Wang S, Cui B, Li X, Xu J and
Ning G: Deletion of steroid receptor coactivator-3 gene ameliorates
hepatic steatosis. J Hepatol. 55:445–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
